BCLI Other | BRAINSTORM CELL THERAPEUTICS INC.

BRAINSTORM CELL THERAPEUTICS INC. Other

Cover page items of the 10-K and 10-Q that have no other home: a security other than the listed stock or a bond, a check box that differs from the latest cover, or a figure not in the Balance Sheet › Equity tabs. Newest first, as filed.

2025-05-15: Form 10-Q; Item Stock registered under Section 12(b); As filed Common Stock, $0.00005 par value · BCLI · NASDAQ.
2025-03-31: Form 10-K; Item Stock registered under Section 12(b); As filed Common Stock, $0.00005 par value · BCLI · NASDAQ.
2024-11-14: Form 10-Q; Item Stock registered under Section 12(b); As filed Common Stock, $0.00005 par value · BCLI · NASDAQ.
2024-08-14: Form 10-Q; Item Stock registered under Section 12(b); As filed Common Stock, $0.00005 par value · BCLI · NASDAQ.

Filed	Form	Item	As filed
2025-05-15	10-Q	Stock registered under Section 12(b)	Common Stock, $0.00005 par value · BCLI · NASDAQ
2025-03-31	10-K	Stock registered under Section 12(b)	Common Stock, $0.00005 par value · BCLI · NASDAQ
2024-11-14	10-Q	Stock registered under Section 12(b)	Common Stock, $0.00005 par value · BCLI · NASDAQ
2024-08-14	10-Q	Stock registered under Section 12(b)	Common Stock, $0.00005 par value · BCLI · NASDAQ
2024-05-14	10-Q	Stock registered under Section 12(b)	Common Stock, $0.00005 par value · BCLI · NASDAQ
2024-04-01	10-K	Stock registered under Section 12(b)	Common Stock, $0.00005 par value · BCLI · NASDAQ
2023-11-14	10-Q	Stock registered under Section 12(b)	Common Stock, $0.00005 par value · BCLI · NASDAQ
2023-08-14	10-Q	Stock registered under Section 12(b)	Common Stock, $0.00005 par value · BCLI · NASDAQ
2023-05-15	10-Q	Stock registered under Section 12(b)	Common Stock, $0.00005 par value · BCLI · NASDAQ
2023-03-30	10-K	Public float as of 2022-06-30	$92.96M
2023-03-30	10-K	Stock registered under Section 12(b)	Common Stock, $0.00005 par value · BCLI · NASDAQ
2022-11-14	10-Q	Stock registered under Section 12(b)	Common Stock, $0.00005 par value · BCLI · NASDAQ
2022-08-15	10-Q	Stock registered under Section 12(b)	Common Stock, $0.00005 par value · BCLI · NASDAQ
2022-05-16	10-Q	Stock registered under Section 12(b)	Common Stock, $0.00005 par value · BCLI · NASDAQ
2022-03-28	10-K	Stock registered under Section 12(b)	Common Stock, $0.00005 par value · BCLI · NASDAQ
2021-11-15	10-Q	Stock registered under Section 12(b)	Common Stock, $0.00005 par value · BCLI · NASDAQ
2021-08-05	10-Q	Stock registered under Section 12(b)	Common Stock, $0.00005 par value · BCLI · NASDAQ
2021-04-26	10-Q	Stock registered under Section 12(b)	Common Stock, $0.00005 par value · BCLI · NASDAQ
2021-02-04	10-K	Stock registered under Section 12(b)	Common Stock, $0.00005 par value · BCLI · NASDAQ
2020-10-15	10-Q	Stock registered under Section 12(b)	Common Stock, $0.00005 par value · BCLI · NASDAQ
2020-08-05	10-Q	Stock registered under Section 12(b)	Common Stock, $0.00005 par value · BCLI · NASDAQ
2019-03-29	10-K	Shares outstanding as of 2019-03-28	29,490,610

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
INTENSITY THERAPEUTICS, INC. (INTS)	United States	$0.013B	-1.08
Pluri Inc. (PLUR)		$0.014B
IN8BIO, INC. (INAB)	United States	$0.012B	-0.76
Senti Biosciences Holdings, Inc. (SNTI)	United States	$0.011B	-0.70
Passage BIO, Inc. (PASG)	United States	$0.015B	-0.43
DYADIC INTERNATIONAL INC (DYAI)	United States	$0.016B
BioCardia, Inc. (BCDA)	United States	$0.016B
TScan Therapeutics, Inc. (TCRX)	United States	$0.008B	-1.23
CERO THERAPEUTICS HOLDINGS, INC. (CERO)	United States	$0.007B
Jasper Therapeutics, Inc. (JSPR)	United States	$0.020B	-0.37